1885-3 |
Apolipoprotein C |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Apolipoprotein C [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
1885-3 |
|
|
|
|
Both |
|
|
|
0 |
Apo C SerPl-mCnc |
|
|
|
Y |
|
APO; Apo C; Apolipo; Apolipoprot; Apolipoproteins; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.4 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
18850-8 |
Fetal presentation |
Type |
Pelvis |
Pt |
Nar |
US |
|
ACTIVE |
Narrative Fetal presentation US |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
OB.US |
|
18850-8 |
|
US |
|
|
|
|
|
|
0 |
Fet pres US |
|
|
|
|
|
Echography; Fet pres; Gyn; Gynecology; Narrative; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Pelvic; Point in time; Random; Report; Sonogram; Sonograph; Sonography; Typ; ULS; Ultrasound |
2.4 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18851-6 |
Grade |
Type |
Placenta^Fetus |
Pt |
Nar |
US |
|
ACTIVE |
Fetal Placenta Grade US (narrative) |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
OB.US |
|
18851-6 |
|
US |
|
|
|
|
|
|
0 |
Fet Placenta Grade - NAR US |
|
|
|
|
|
Echography; Fetal; Gyn; Gynecology; Narrative; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Placent; Placental; Point in time; Random; Report; Sonogram; Sonograph; Sonography; Typ; ULS; Ultrasound |
2.38 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18852-4 |
Surgical drains |
Find |
Surgery^Patient |
Pt |
Nar |
|
|
DEPRECATED |
Deprecated Operative note - surgical drains (narrative) |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ATTACH.CLINRPT |
|
18852-4 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
|
|
ATTACH; ATTACH.CLINRPT; Finding; Findings; Narrative; Point in time; Random; Report; Srgry; Surg |
2.36 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
18855-7 |
5-Fluorocytosine |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
5-Fluorocytosine [Susceptibility] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
18855-7 |
|
|
|
|
Observation |
|
|
|
0 |
5-fluorocytosine Susc Islt |
|
|
|
|
|
Alcobon; Ancobon; Ancotil; ANTIBIOTIC SUSCEPTIBILITIES; AST; Flucytosine; Fluorocytosin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18857-3 |
Almecillin |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Almecillin [Susceptibility] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
18857-3 |
|
|
|
|
Observation |
|
|
|
0 |
Almecillin Susc Islt |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.19 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18859-9 |
Amdinocillin |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Amdinocillin [Susceptibility] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
18859-9 |
|
|
|
|
Observation |
|
|
|
0 |
Amdinocillin Susc Islt |
|
|
|
|
|
Amdinocillin pivoxil; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Mecillinam; Pivmecilliam; Point in time; Random; Selexid; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.19 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
1886-1 |
Apolipoprotein E |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Apolipoprotein E [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
CHEM |
|
1886-1 |
|
|
|
|
Both |
|
|
|
0 |
Apo E SerPl-mCnc |
|
|
|
Y |
|
APO; Apo E; ApoE; Apolipo; Apolipoprot; Apolipoprotein Epsilon; Apolipoproteins; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
1 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
18860-7 |
Amikacin |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Amikacin [Susceptibility] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
18860-7 |
|
|
|
|
Observation |
|
|
|
0 |
Amikacin Susc Islt |
|
|
|
|
|
Amikin; Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18861-5 |
Amoxicillin |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Amoxicillin [Susceptibility] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
18861-5 |
|
|
|
|
Observation |
|
|
|
0 |
Amoxicillin Susc Islt |
|
|
|
|
|
Amox; Amoxicilloyl; Amoxil; ANTIBIOTIC SUSCEPTIBILITIES; AST; Bristamox; c204; c6; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Larotid; Moxalin; Point in time; Polymox; Random; Sumox; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Trimox; Wymox |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18862-3 |
Amoxicillin+Clavulanate |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Amoxicillin+Clavulanate [Susceptibility] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
18862-3 |
|
|
|
|
Observation |
|
|
|
0 |
Amoxicillin+Clav Susc Islt |
|
|
|
|
|
Amox; Amoxicillin+clavulanic acid; Amoxicilloyl; Amoxil; ANTIBIOTIC SUSCEPTIBILITIES; AST; Augmentin; Bristamox; c204; c305; c6; Clav; Clavate; Clavu; Clavul; Clavulanic; Clavulanic acid; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Larotid; Moxalin; Moxicillin+clavulanic acid; Point in time; Polymox; Random; Sumox; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Trimox; Wymox |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18863-1 |
Amphotericin B |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Amphotericin B [Susceptibility] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
18863-1 |
|
|
|
|
Observation |
|
|
|
0 |
Amphotericin B Susc Islt |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; Fungizone; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18864-9 |
Ampicillin |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Ampicillin [Susceptibility] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
18864-9 |
|
|
|
|
Observation |
|
|
|
0 |
Ampicillin Susc Islt |
|
|
|
|
|
Amcil; Amicil; Amp; Ampicilloyl; ANTIBIOTIC SUSCEPTIBILITIES; AST; c203; c5; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Omnipen; Penbritin; Point in time; Polycillin; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18865-6 |
Ampicillin+Sulbactam |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Ampicillin+Sulbactam [Susceptibility] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
18865-6 |
|
|
|
|
Observation |
|
|
|
0 |
Ampicillin+Sulbac Susc Islt |
|
|
|
|
|
Amcil; Amicil; Amp; Ampicilloyl; ANTIBIOTIC SUSCEPTIBILITIES; AST; c203; c5; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Omnipen; Penbritin; Point in time; Polycillin; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Unasyn |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18866-4 |
Azithromycin |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Azithromycin [Susceptibility] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
18866-4 |
|
|
|
|
Observation |
|
|
|
0 |
Azithromycin Susc Islt |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Zithromax |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18867-2 |
Azlocillin |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Azlocillin [Susceptibility] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
18867-2 |
|
|
|
|
Observation |
|
|
|
0 |
Azlocillin Susc Islt |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; Azlin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Securopen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.19 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18868-0 |
Aztreonam |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Aztreonam [Susceptibility] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
18868-0 |
|
|
|
|
Observation |
|
|
|
0 |
Aztreonam Susc Islt |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; Azactam; Azaj; azthreonam; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18869-8 |
Bacampicillin |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Bacampicillin [Susceptibility] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
18869-8 |
|
|
|
|
Observation |
|
|
|
0 |
Bacampicillin Susc Islt |
|
|
|
|
|
Albaxin; Ambacamp; Ambaxin; Amplibac; ANTIBIOTIC SUSCEPTIBILITIES; AST; Bacacil; Bacampicin; Bacocil; Carampicillin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Penglobe; Point in time; Random; Sprectrobid; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Velbacampin |
2.19 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
1887-9 |
Observation |
Aper |
Amnio fld |
Pt |
Nom |
|
|
ACTIVE |
Appearance of Amniotic fluid |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SPEC |
|
1887-9 |
|
|
|
|
Observation |
|
|
|
0 |
Appearance Amn |
|
|
|
|
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Appearance; Nominal; Point in time; Random; SPEC |
2.79 |
1 |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by coll w SCT: component that the description is property like as in Color, Appearance, Osmolality have changed to Component: Observation, and Property: Color, or Appearance, or Osmolality, so forth�; |
0 |
18870-6 |
Bacitracin |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Bacitracin [Susceptibility] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
18870-6 |
|
|
|
|
Observation |
|
|
|
0 |
Bacitracin Susc Islt |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.19 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18871-4 |
Butirosin |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Butirosin [Susceptibility] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
18871-4 |
|
|
|
|
Observation |
|
|
|
0 |
Butirosin Susc Islt |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.19 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18872-2 |
Capreomycin |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Capreomycin [Susceptibility] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
18872-2 |
|
|
|
|
Observation |
|
|
|
0 |
Capreomycin Susc Islt |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; CAPASTAT; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Ogostal; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.19 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18873-0 |
Carbenicillin |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Carbenicillin [Susceptibility] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
18873-0 |
|
|
|
|
Observation |
|
|
|
0 |
Carbenicillin Susc Islt |
|
|
|
|
|
Anabactyl; ANTIBIOTIC SUSCEPTIBILITIES; AST; c247; Carbenicill; Fugacillin; Geocillin; Geopen; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microcillin; Point in time; Pyocianil; Pyopen; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18874-8 |
Cefaclor |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Cefaclor [Susceptibility] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
18874-8 |
|
|
|
|
Observation |
|
|
|
0 |
Cefaclor Susc Islt |
|
|
|
|
|
Alfatil; ANTIBIOTIC SUSCEPTIBILITIES; AST; c7; Ceclor; Distaclor; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Kefalor; Panacef; Panoral; Point in time; Random; Rc7; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |
18875-5 |
Cefadroxil |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Cefadroxil [Susceptibility] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
18875-5 |
|
|
|
|
Observation |
|
|
|
0 |
Cefadroxil Susc Islt |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; Bidocef; Cefadril; Cefadrox; Cefamox; Cefroxil; Cehpos; Ceoxil; Crenodyn; Droxicef; Duracef; Duricef; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.19 |
1.0l |
|
|
|
|
|
|
|
|
|
|
|
0 |